Autism data hits ‘registration benchmark’ as Neurotech prepares for Phase III clinical trial by Adam Sheldon March 25, 2026March 26, 2026 Neurotech International has said data from its Phase II/III autism trial already sits within the range […]
News in brief: Vitura signs MedReleaf deal; Neurotech initiates first site for Phase 3 autism trial by Adam Sheldon March 17, 2026March 17, 2026
Survey of 239 patients suggests CBG may benefit pain, sleep and anxiety by Adam Sheldon March 9, 2026March 10, 2026
